Reliq Health Technologies, Inc. Announces Four New US


HAMILTON, Ont., July 19, 2022 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV: RHT or OTC: RQHTF or WKN: A2AJTB) (“reliq“or the”Company), a rapidly growing global health technology company that develops innovative virtual care solutions for the multi-billion dollar healthcare market, today announced that it has signed new contracts with four practices hospitals in California and Texas to add more than 5,000 new patients to its platform. The company is also pleased to announce that it has commissioned the first client through its partnership agreement with Data Soft Logic. Integration with Data Soft Logic is expected to accelerate over the remainder of 2022, adding more than 50,000 patients per year to Reliq’s iUGO Care platform in 2023 and beyond.

“We are excited to add four new medical practices in California and Texas,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies, Inc. “Together, these customers are expected to add more than 5,000 patients to our platform over the course of of the next nine months. at an average revenue of $50 per patient per month at 75% gross margin. Integration with these customers is expected to begin next month.

“We are also very pleased to bring our first customer online through our partnership with Data Soft Logic. Onboarding has already begun with the customer. Data Soft Logic is a provider of home care and palliative care solutions cloud-based applications that include point-of-care, billing, scheduling, accounting, and human resources applications.Their solutions are currently used by more than 600 home care and hospice agencies across the United States Data Soft Logic’s home care and palliative care customers work with more than 1,000 primary care physicians who provide care to more than 500,000 Medicare and Medicaid patients.As previously reported, the company plans to add more 50,000 patients per year on the platform from 2023 thanks to the partnership with Data Soft Logic, at an average revenue of $60 per patient per month (at 75% gross margin). remains on track to have over 100,000 patients on our iUGO Care platform by December 31, 2022.”

About Data Soft Logic
Data Soft Logic Corporation is a cloud-based home healthcare and palliative care solution offering a suite of applications including point of care, symptom management, billing, scheduling, accounting and human resources. Data Soft Logic software is powerful and meaningful with ease of use for superior connected care at the point of delivery. We have proudly partnered with home care, palliative care and therapy agencies for over 10 years. Learn more at

Reliq Health
Reliq Health Technologies is a rapidly growing global health technology company specializing in the development of innovative virtual care solutions for the multi-billion dollar healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care enables complex patients to receive high-quality care at home, improving health outcomes, improving the quality of life for patients and families, and reducing the cost of delivering care. iUGO Care provides real-time access to remote patient monitoring data, enabling rapid care team interventions to avoid costly hospital readmissions and emergency room visits. Reliq Health Technologies trades on the TSX Venture Exchange under the symbol RHT, on the OTC as RQHTF and on the Frankfurt Stock Exchange under the name WKN:A2AJTB.

“Dr. Lisa Crossley”
CEO and Director

For more information, please contact:

Company details
Investor Relations at [email protected]

US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Chamsyan
New York | Phoenix
[email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautions Regarding Forward-Looking Information
Certain statements contained in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including, without limitation, statements regarding future estimates, plans, programs, forecasts, projections, goals, assumptions, expectations or beliefs, are “forward-looking statements”.

We caution you that these “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in these statements.

Forward-looking statements include, but are not limited to, statements regarding business operations, including technology development, anticipated revenues, projected market size, and other information based on forecasts of future results, estimates of amounts not yet determinable and management assumptions.

Reliq Health Technologies Inc. (the “Company“) does not intend and assumes no obligation to update these forward-looking statements, except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technological development and marketing activities, company history, technology development experience, uninsured risks Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.


Comments are closed.